Sonoma Pharmaceuticals Inc (SNOA)

NASDAQ
1.690
-0.330(-16.34%)
Pre Market
1.680
-0.010(-0.59%)
- Real-time Data
  • Volume:
    801,344
  • Day's Range:
    1.690 - 1.990
  • 52 wk Range:
    1.000 - 4.250
Earnings results expected in 9 days

Sonoma Pharma will announce its quarterly financial results in 9 days. Traders should take this into account as the share price often fluctuates around this time period.

SNOA Overview

Prev. Close
2.02
Day's Range
1.69-1.99
Revenue
10.21M
Open
1.99
52 wk Range
1-4.25
EPS
-1.87
Volume
801,344
Market Cap
5.24M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,537,406
P/E Ratio
-0.92
Beta
1.04
1-Year Change
-53.19%
Shares Outstanding
3,102,972
Next Earnings Date
Feb 09, 2023
What is your sentiment on Sonoma Pharma?
or
Market is currently closed. Voting is open during market hours.

Sonoma Pharmaceuticals Inc News

Sonoma Pharmaceuticals Inc Analysis

Sonoma Pharmaceuticals Inc Company Profile

Sonoma Pharmaceuticals Inc Company Profile

Employees
12

Sonoma Pharmaceuticals, Inc. is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. The Company's product offerings include Acuicyn, Endocyn, OroGenix Oral Hygiene Rinse, Microdacyn60 Oral Care, Sinudox, MicrocynAH, Nanocyn Disinfectant & Sanitizer, Epicyn Antimicrobial Facial Cleanser, Levicyn Antimicrobial Dermal Spray, Levicyn Antipruritic Gel, Levicyn Antipruritic Spray Gel, Celacyn Scar Management Gel and Sebuderm Topical Gel. Acuicyn is an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes and helps manage red, itchy, crusty and inflamed eyes. MicrocynAH is a HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections. Celacyn offers scar management by protecting and moisturizing wound and scar sites.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellNeutralNeutralStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellSellBuyStrong Sell
  • bullish
    0
    • Cheapest nasdaq stock
      1
      • Whos encourage this shares and why?
        0
        • Hi
          0
          • i see they have products already manufactured. what do you think is the futute of this stock and company?
            0
            • of course
              0
          • https://seekingalpha.com/news/3643562-sonoma-pharmaplus-35-on-crown-laboratories-partnership
            0
            • is there a delay to announce the 2nd Quarter earning.
              0
              • What's going on?
                0
                • is this a vaccine?
                  0